The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal.

MLA

Toma, Wisam, et al. “The Α7 Nicotinic Receptor Silent Agonist R-47 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice without Tolerance or Altering Nicotine Reward and Withdrawal.” Experimental Neurology, vol. 320, Oct. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.expneurol.2019.113010.

APA

Toma, W., Kyte, S. L., Bagdas, D., Jackson, A., Meade, J. A., Rahman, F., Chen, Z.-J., Del Fabbro, E., Cantwell, L., Kulkarni, A., Thakur, G. A., Papke, R. L., Bigbee, J. W., Gewirtz, D. A., & Damaj, M. I. (2019). The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal. Experimental Neurology, 320, N.PAG. https://doi.org/10.1016/j.expneurol.2019.113010

Chicago

Toma, Wisam, S. Lauren Kyte, Deniz Bagdas, Asti Jackson, Julie A. Meade, Faria Rahman, Zhi-Jian Chen, et al. 2019. “The Α7 Nicotinic Receptor Silent Agonist R-47 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice without Tolerance or Altering Nicotine Reward and Withdrawal.” Experimental Neurology 320 (October): N.PAG. doi:10.1016/j.expneurol.2019.113010.